Overview

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Status:
Completed
Trial end date:
2021-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and clinical efficacy of HGP1910 and HCP1903 in patients with primary hypercholesterolemia
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited